Navigation Links
Stayhealthy and Innovative Wellness Solutions Announce Partnership to Bring Innovation to the Workplace Wellness Market
Date:7/21/2009

BALTIMORE, July 21 /PRNewswire/ -- Stayhealthy, Inc., a leader in bringing advanced technologies and solutions to people that want to take control of their health, and Innovative Wellness Solutions a leader in bringing comprehensive proactive health solutions to employers announced that they have reached an agreement to bring a powerful new solution to employers as they strive to help their employees - "stay healthy."

Wellness in the workplace has become a mission for most employers. As healthcare costs continue to escalate, employers are increasingly focusing on strategies to keep their workers healthy. Stuart Sutley, founder and CEO of Baltimore-based Innovative Wellness Solutions, one of only 12 URAC accredited wellness companies in the United States, said, "Employers understand the importance of health benefits for their employees as a way to recruit and retain talent." While "health" is one of the most personal topics, employers want to bring tools and resources to their employees, (and dependents) that will help them attain their health goals.

The foundation for Stayhealthy's solution is "body composition" analysis. "With nearly 70% of the U.S. population defined as overweight - excess body fat is the number one factor driving the incidence and severity of the most costly and debilitating chronic health conditions," said Brian Baum, President of Stayhealthy. The reality is it is time to stop looking at total weight as a measure of health. The health risk factor lies in excess body fat, or the ratio of lean mass to body fat, not total "pounds." Stayhealthy provides tools and services that help people understand their specific health situation, establish personalized plans and monitor the progress as their body composition evolves to a healthy ratio of lean mass to body fat.

Stayhealthy's technology also measures individual hydration levels. As the ma
'/>"/>

SOURCE Stayhealthy, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. New Stayhealthy Body Composition Technology Announced at Microsofts Connected Health Conference
2. Innovative Prostate Cancer Treatment Known as Sonablate(R) HIFU Now Available at Third Site in India
3. Ready? AIM! Target Success! AIM Expands Global Reach Through Innovative Corporate Portal ... from Web to Enterprise 2.0
4. IBM Award for Innovative Solution to Tackling Worlds Most Critical Social and Environmental Problems
5. Frost & Sullivan Lauds Marigot Ltd. and GTC Nutrition for Their Innovative CalciLife(TM)
6. Nutrition 21 Launches New Innovative PRESCRIPTIX(TM) Nutraceuticals Product Line
7. Frost & Sullivan Identifies Innovative and Cost-Effective Technology as Key Competitive Factor in European Medical Device Market
8. Charlotte Cowan MD Honored by Obama Administration for Innovative Doctor Hippo Series of Childrens Books
9. Intelligent Hospital Systems Receives International Award for Innovative Technology Benefiting Society
10. InfoWallet, A New Innovative Secure, Portable, Multi-Platform, Personal Life Manager Software Is Now Available
11. NTU receives $2.7 million research funds for innovative water quality monitoring technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2012)... acne, and they deal with the embarrassing skin ... Accutane or Roaccutane. Now, however, research from Tel ... cause eye infections such as conjunctivitis (pink eye) ... of TAU,s School of Public Health at the ... a connection between acne and eye infections, but ...
(Date:5/23/2012)... genes? Researchers from The Miriam Hospital,s Weight Control and Diabetes ... tend to eat more meals and snacks, consume more calories ... fat, sugary foods. , Their study, published online by the ... the June issue, reveals certain variations within the FTO and ... may play a role in eating habits that can ...
(Date:5/23/2012)... University in Sweden shows that phthalates from PVC flooring ... substances suspected to cause asthma and allergies, as well ... that children can ingest these softening agents with food ... Phthalates are a group of chemical compounds that occur ... consumer goods such as toys, cleaning solvents, packaging, etc. ...
(Date:5/23/2012)... May 23 (HealthDay News) -- The use of ... through a multi-pronged approach that includes more training ... according to a new German study. Despite ... physical restraints such as bed rails and belts ... recent survey found that the rate of physical-restraint ...
(Date:5/23/2012)... Researchers in the United Kingdom have determined that ... properties, can be an effective treatment option for ... life-threatening complication that occurs in the majority of ... the leading cause of mortality after the first ... the body repeatedly rejects the transplanted lung tissue. ...
Breaking Medicine News(10 mins):Health News:Common acne medication doubles risk of eye infection 2Health News:'Obesity genes' may influence food choices, eating patterns 2Health News:Phthalates in PVC floors taken up by the body in infants 2Health News:Study Offers Ways to Decrease Use of Restraints at Nursing Homes 2Health News:Study shows antibiotic improves respiratory function in lung transplant patients 2
... Securities until February 15, ... ... KV Pharmaceutical Company,(NYSE: KVa/KVb) a fully integrated specialty pharmaceutical company that,develops, ... today that NYSE Regulation, Inc. has granted KV,s request for a,trading ...
... Recommendations cite importance of restricted calorie intake for diabetics ... (HealthDay News) -- For the first time, the American ... low-carbohydrate diets for people with diabetes who want to ... of low-calorie or low-carbohydrate diets in its ...
... PITTSBURGH, Dec. 28 Mylan Inc. (NYSE: MYL ... approval,from the U.S. Food and Drug Administration (FDA) for ... (OTC), 5 mg,and 10 mg., Cetirizine HCl Tablets ... U.S. sales of approximately $1.4 billion for the 12,months ...
... the United States, the management of glaucoma costs about ... direct costs, glaucoma medications account for an estimated 38% ... in the January 2008 issue of the American Journal ... Health Science Center College of Medicine, Temple, Texas; analyzed ...
... -- Featuring an Interactive Arcade for Kids, Teens, and ... Fitworks largest 59,000,sq. ft. Mega-Center officially opened for ... in West Chester just off Cincinnati-Dayton,Road & I-75 next ... for January which includes a silent auction on Saturday, ...
... Eclipsys Corporation(R),(Nasdaq: ECLP ), The Outcomes Company(R), ... JPMorgan Healthcare Conference taking place from,January 7th - ... http://www.newscom.com/cgi-bin/prnh/20050209/FLW006LOGO ), Eclipsys executives will present ... p.m. Pacific time. To access the live presentation ...
Other Medicine News:Health News:KV Pharmaceutical Company Announces NYSE Listing Extension 2Health News:KV Pharmaceutical Company Announces NYSE Listing Extension 3Health News: Diabetes Group Backs Low-Carb Diets 2Health News:Cost of glaucoma medications may impact treatment 2Health News:Fitworks West Chester Mega-Center Now Open 2Health News:Fitworks West Chester Mega-Center Now Open 3Health News:Eclipsys to Present at JPMorgan Healthcare Conference 2Health News:Eclipsys to Present at JPMorgan Healthcare Conference 3
(Date:5/23/2012)... Tactile, Inc. (MTI), with the support of The Pre-Mammogram ... developed a pre-commercial SureTouch™ Wireless system that ... According to a publication funded by ... were diagnosed with breast cancer in 2010 and 425,000 ... the best means to a good prognosis for breast ...
(Date:5/23/2012)... 2012   CryoLife, Inc. (NYSE: ... cardiac and vascular surgery, announced today that it will ... One-on-One Investor Conference on Thursday, May 31, 2012 in ... chief operating officer, and chief financial officer of CryoLife, ... conference will allow institutional investors to meet with the ...
(Date:5/23/2012)... 2012 QRxPharma Limited (ASX: QRX and OTCQX: ... Trademark Office (USPTO) issued the Company U.S. Patent No. ... covers a method of treatment of pain comprising the ... compositions of MoxDuo IR (Immediate Release) for the ... (Controlled Release) for the treatment of chronic pain. ...
Breaking Medicine Technology:Medical Tactile, Inc. Announces a 3G-Wireless System for Breast Cancer Screening 2Medical Tactile, Inc. Announces a 3G-Wireless System for Breast Cancer Screening 3Medical Tactile, Inc. Announces a 3G-Wireless System for Breast Cancer Screening 4CryoLife to Participate in 3rd Annual Benchmark Company, LLC One-on-One Investor Conference 2QRxPharma Granted Additional US Patent on MoxDuo® 2QRxPharma Granted Additional US Patent on MoxDuo® 3Rcadia Medical Imaging Awarded Four U S Patents Covering Technology for Automated Analysis of Coronary CT Angiography 18466 1Rcadia Medical Imaging Awarded Four U S Patents Covering Technology for Automated Analysis of Coronary CT Angiography 18466 2Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 1Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 2Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 3Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 4Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 5Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 6Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 7Morphotek AE Inc Announces Initiation of Farletuzumab Phase II Study in First Line Treatment of Non Small Cell Lung Cancer 18460 1Morphotek AE Inc Announces Initiation of Farletuzumab Phase II Study in First Line Treatment of Non Small Cell Lung Cancer 18460 2Morphotek AE Inc Announces Initiation of Farletuzumab Phase II Study in First Line Treatment of Non Small Cell Lung Cancer 18460 3Morphotek AE Inc Announces Initiation of Farletuzumab Phase II Study in First Line Treatment of Non Small Cell Lung Cancer 18460 4
... NovaDel Pharma,Inc. (AMEX: NVD), a specialty pharmaceutical ... range of marketed treatments,today announced that its ... zolpidem tablets have met their primary,pharmacokinetic (PK), ... currently marketed as Ambien(R), a leading,drug for ...
... Oral Presentation Reports Significantly More Patients ... Least Three,Years, CHICAGO, June 04, 2007 ... (Taxotere plus,prednisone) maintained long-term efficacy as ... cancer patients,according to the three-year updated ...
Other Medicine Technology:NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 2NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 3NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 4NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 5NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 6NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 7Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 2Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 3Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: